Biomarck Pharmaceuticals presents at H.C. Wainwright 2021 Global Life Sciences Conference on March 9-10, 2021
NEWTOWN, Pa.–(BUSINESS WIRE)–Biomarck Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company focused on developing peptides that inhibit MARCKS to treat patients with inflammatory diseases, today announced that Dr. Graham G. Lumsden, president and chief executive officer of Biomarck, will present at the H.C. Wainwright 2021 Global Life Sciences Conference, being held March 9-10, 2021.
The presentation will be available to registered conference attendees for on-demand viewing beginning March 9, 2021 at 7:00 a.m. ET and will also be available in the investor section of the company’s website at www.biomarck.com. The webcast will be archived for 60 days following the presentation.